NGL Fine-Chem Limited (NGLFINE) Share Price & AI Investment Analysis

NGL Fine-Chem Limited develops and manufactures veterinary APIs, human APIs, intermediates, and finished dosage forms in India, Europe, the Asia Pacific, the United States, and internationally. The company offers afoxolaner, amitraz, atovaquone, buparvaquone, butaphosphan, carprofen, clorsulon, closantel base, closantel sodium, decoquinate, diminazene diaceturate, febantel, fenbendazole, fluazuron, flumethrin, flunixin meglumine, fluralaner, halquinol, homidium chloride, imidocarb dipropionate, isometamidium chlroide HCl, lotilaner, marbofloxacin, maropitant citrate monohydrate, nitroscanate,. Track NGL Fine-Chem Limited's live NSE:NGLFINE share price ₹2,859.40 (+4.68%), market cap ₹₹18B, P/E 30.9. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for NGLFINE — real-time NSE India stock intelligence.